Diversify Advisory Services, LLC
Position in BTAI — BioXcel Therapeutics, Inc.
CIK 2021232
SANDY, UT
Position in BTAI
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$21,150
New position
Shares Held
15,000
first reported quarter
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 46 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diversify Advisory Services, LLC holds $4,800,771 across 8 Drug Manufacturers - Specialty & Generic names. BTAI ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
70,713 | $2,395,756 | |
| 2 | ZTS |
Zoetis Inc.
|
12,806 | $920,239 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
2,506 | $422,361 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
17,746 | $307,183 | |
| 5 | TRLV |
Trulieve Cannabis Corp.
|
27,096 | $266,353 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
5,491 | $259,559 | |
| 7 | HLN |
Haleon plc
|
22,312 | $208,170 | |
| 8 | BTAI |
BioXcel Therapeutics, Inc.
This page
|
15,000 | $21,150 |
All Filings in BTAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,150 | 15,000 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||